Also trades as: KLBF.JK (JKT) · $vol 3M

$0.05

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 54 · $2.4B mcap · 17.49B float · 0.0000% daily turnover · Short 79% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$32.63T +7.2% ▲

5Y CAGR: +7.6%

Gross Profit

$12.96T +12.2% ▲

5Y CAGR: +4.8%

Operating Income

$4.07T +12.0% ▲

5Y CAGR: +3.5%

Net Income

$3.24T +17.1% ▲

5Y CAGR: +5.3%

EPS (Diluted)

$70.22 +17.4% ▲

5Y CAGR: +5.6%

EBITDA

$4.61T +4.1% ▲

5Y CAGR: +3.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$23.11T	$26.26T	$28.93T	$30.45T	$32.63T
YoY Growth	+2.1%	+13.6%	+10.2%	+5.2%	+7.2%
Cost of Revenue	$12.87T	$14.98T	$17.23T	$18.90T	$19.67T
Gross Profit	$10.25T	$11.28T	$11.70T	$11.55T	$12.96T
Gross Margin	44.3%	43.0%	40.5%	37.9%	39.7%
R&D Expenses	$483.8B	$532.8B	$288.3B	$329.6B	$471.6B
SG&A Expenses	$3.35T	$3.86T	$4.05T	$4.45T	$4.76T
Operating Expenses	$6.70T	$7.28T	$7.47T	$7.92T	$8.89T
Operating Income	$3.64T	$4.16T	$4.49T	$3.63T	$4.07T
Operating Margin	15.7%	15.8%	15.5%	11.9%	12.5%
Interest Expense	$75.8B	$45.5B	$41.2B	$95.1B	$56.3B
Income Before Tax	$3.63T	$4.14T	$4.46T	$3.61T	$4.22T
Tax Expense	$828.0B	$911.3B	$1.01T	$827.8B	$972.3B
Net Income	$2.73T	$3.18T	$3.38T	$2.77T	$3.24T
Net Margin	11.8%	12.1%	11.7%	9.1%	9.9%
EPS (Diluted)	$58.31	$67.92	$72.71	$59.81	$70.22
EBITDA	$4.35T	$4.87T	$5.25T	$4.43T	$4.61T
Shares Outstanding	46.87B	46.87B	46.52B	46.26B	46.15B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$7.91T	$8.39T	$8.85T	$8.23T	$8.86T	$9.34T	$9.70T	$9.87T
Cost of Revenue	$4.64T	$4.95T	$5.17T	$4.88T	$5.49T	$5.84T	$6.09T	$6.33T
Gross Profit	$3.27T	$3.44T	$3.68T	$3.35T	$3.38T	$3.50T	$3.61T	$3.54T
Gross Margin	41.3%	41.0%	41.6%	40.7%	38.1%	37.5%	37.2%	35.9%
R&D Expenses	$193.3B	$154.1B	$103.5B	$137.0B	$56.1B	$154.3B	$95.7B	$92.7B
SG&A Expenses	$1.24T	$1.19T	$1.30T	$1.30T	$2.39T	$1.16T	$1.34T	$1.52T
Operating Expenses	$2.29T	$2.36T	$2.30T	$2.30T	$2.57T	$2.22T	$2.30T	$2.38T
Operating Income	$700.5B	$1.08T	$1.38T	$1.05T	$805.4B	$1.28T	$1.31T	$1.16T
Operating Margin	8.9%	12.9%	15.6%	12.8%	9.1%	13.7%	13.5%	11.8%
Interest Expense	$12.7B	$15.4B	$9.4B	$10.4B	$13.4B	$5.8B	$8.3B	$10.6B
Income Before Tax	$724.6B	$1.13T	$1.43T	$1.18T	$859.8B	$1.30T	$1.35T	$1.19T
Tax Expense	$159.1B	$276.6B	$318.8B	$265.9B	$196.6B	$251.7B	$299.9B	$264.6B
Net Income	$573.3B	$862.3B	$1.08T	$898.2B	$653.0B	$1.03T	$1.03T	$896.9B
Net Margin	7.2%	10.3%	12.2%	10.9%	7.4%	11.1%	10.6%	9.1%
EPS (Diluted)	$12.42	$18.68	$23.57	$19.46	$14.92	$22.71	$22.74	$19.78
EBITDA	$818.3B	$1.22T	$1.52T	$1.30T	$1.08T	$1.39T	$1.51T	$1.37T
Shares Outstanding	46.15B	46.15B	46.15B	46.15B	45.32B	45.52B	45.25B	45.25B

PTKFF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet